Birchview Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Birchview Capital’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,000	Closed	-$576K	–	53
2023 Q2	$576K	Hold	15,000	–	–	0.43%	35
2023 Q1	$347K	Buy	+15,000	New	+$358K	0.27%	38

Birchview Capital's KDNY Position: Q3 2023 in Review

Birchview Capital sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 15,000 shares — an estimated $576K sold.

Birchview Capital first reported a position in KDNY in Q1 2023 and held it in 2 quarters. The position peaked at $576K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Birchview Capital reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Birchview Capital sold 15,000 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $576K.
Birchview Capital first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Birchview Capital's Chinook Therapeutics, Inc. Common Stock position peaked at $576K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Birchview Capital's 13F filing for Q3 2023, filed 14 Nov 2023.